Transplantation of bioengineered liver capable of extended function in a preclinical liver failure model
© 2021 The American Society of Transplantation and the American Society of Transplant Surgeons..
Unlimited organ availability would represent a paradigm shift in transplantation. Long-term in vivo engraftment and function of scaled-up bioengineered liver grafts have not been previously reported. In this study, we describe a human-scale transplantable liver graft engineered on a porcine liver-derived scaffold. We repopulated the scaffold parenchyma with primary hepatocytes and the vascular system with endothelial cells. For in vivo functional testing, we performed auxiliary transplantation of the repopulated scaffold in pigs with induced liver failure. It was observed that the auxiliary bioengineered liver graft improved liver function for 28 days and exhibited upregulation of liver-specific genes. This study is the first of its kind to present 28 days of posttransplant evaluation of a bioengineered liver graft using a preclinical large animal model. Furthermore, it provides definitive evidence for the feasibility of engineering human-scale transplantable liver grafts for clinical applications.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:22 |
|---|---|
| Enthalten in: |
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons - 22(2022), 3 vom: 21. März, Seite 731-744 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Higashi, Hisanobu [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 18.04.2022 Date Revised 24.01.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1111/ajt.16928 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM334682762 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM334682762 | ||
| 003 | DE-627 | ||
| 005 | 20231225224229.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/ajt.16928 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1115.xml |
| 035 | |a (DE-627)NLM334682762 | ||
| 035 | |a (NLM)34932270 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Higashi, Hisanobu |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Transplantation of bioengineered liver capable of extended function in a preclinical liver failure model |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 18.04.2022 | ||
| 500 | |a Date Revised 24.01.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2021 The American Society of Transplantation and the American Society of Transplant Surgeons. | ||
| 520 | |a Unlimited organ availability would represent a paradigm shift in transplantation. Long-term in vivo engraftment and function of scaled-up bioengineered liver grafts have not been previously reported. In this study, we describe a human-scale transplantable liver graft engineered on a porcine liver-derived scaffold. We repopulated the scaffold parenchyma with primary hepatocytes and the vascular system with endothelial cells. For in vivo functional testing, we performed auxiliary transplantation of the repopulated scaffold in pigs with induced liver failure. It was observed that the auxiliary bioengineered liver graft improved liver function for 28 days and exhibited upregulation of liver-specific genes. This study is the first of its kind to present 28 days of posttransplant evaluation of a bioengineered liver graft using a preclinical large animal model. Furthermore, it provides definitive evidence for the feasibility of engineering human-scale transplantable liver grafts for clinical applications | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Research Support, N.I.H., Extramural | |
| 650 | 4 | |a artificial organs/support devices | |
| 650 | 4 | |a bioengineering | |
| 650 | 4 | |a liver transplantation/hepatology | |
| 650 | 4 | |a regenerative medicine | |
| 650 | 4 | |a tissue/organ engineering | |
| 650 | 4 | |a translational research/science | |
| 700 | 1 | |a Yagi, Hiroshi |e verfasserin |4 aut | |
| 700 | 1 | |a Kuroda, Kohei |e verfasserin |4 aut | |
| 700 | 1 | |a Tajima, Kazuki |e verfasserin |4 aut | |
| 700 | 1 | |a Kojima, Hideaki |e verfasserin |4 aut | |
| 700 | 1 | |a Nishi, Kotaro |e verfasserin |4 aut | |
| 700 | 1 | |a Morisaku, Toshinori |e verfasserin |4 aut | |
| 700 | 1 | |a Hirukawa, Kazuya |e verfasserin |4 aut | |
| 700 | 1 | |a Fukuda, Kazumasa |e verfasserin |4 aut | |
| 700 | 1 | |a Matsubara, Kentaro |e verfasserin |4 aut | |
| 700 | 1 | |a Kitago, Minoru |e verfasserin |4 aut | |
| 700 | 1 | |a Shinoda, Masahiro |e verfasserin |4 aut | |
| 700 | 1 | |a Obara, Hideaki |e verfasserin |4 aut | |
| 700 | 1 | |a Adachi, Shungo |e verfasserin |4 aut | |
| 700 | 1 | |a Nishimura, Kumiko |e verfasserin |4 aut | |
| 700 | 1 | |a Natsume, Tohru |e verfasserin |4 aut | |
| 700 | 1 | |a Tomi, Masatoshi |e verfasserin |4 aut | |
| 700 | 1 | |a Soto-Gutierrez, Alejandro |e verfasserin |4 aut | |
| 700 | 1 | |a Kitagawa, Yuko |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons |d 2001 |g 22(2022), 3 vom: 21. März, Seite 731-744 |w (DE-627)NLM119667924 |x 1600-6143 |7 nnns |
| 773 | 1 | 8 | |g volume:22 |g year:2022 |g number:3 |g day:21 |g month:03 |g pages:731-744 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/ajt.16928 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 22 |j 2022 |e 3 |b 21 |c 03 |h 731-744 | ||